Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Toma, Marieta [VerfasserIn]   i
 Wehner-Joachim, Rebekka [VerfasserIn]   i
 Kloß, Anja [VerfasserIn]   i
 Hübner, Linda [VerfasserIn]   i
 Fodelianaki, Georgia [VerfasserIn]   i
 Erdmann, Kati [VerfasserIn]   i
 Füssel, Susanne [VerfasserIn]   i
 Zastrow, Stefan [VerfasserIn]   i
 Meinhardt, Matthias [VerfasserIn]   i
 Seliger, Barbara [VerfasserIn]   i
 Brech, Dorothee [VerfasserIn]   i
 Noessner, Elfriede [VerfasserIn]   i
 Tonn, Torsten [VerfasserIn]   i
 Schäkel, Knut [VerfasserIn]   i
 Bornhäuser, Martin [VerfasserIn]   i
 Bachmann, Michael [VerfasserIn]   i
 Wirth, Manfred [VerfasserIn]   i
 Baretton, Gustavo Bruno [VerfasserIn]   i
 Schmitz, Marc [VerfasserIn]   i
Titel:Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis
Verf.angabe:Marieta Toma, Rebekka Wehner, Anja Kloß, Linda Hübner, Georgia Fodelianaki, Kati Erdmann, Susanne Füssel, Stefan Zastrow, Matthias Meinhardt, Barbara Seliger, Dorothee Brech, Elfriede Noessner, Torsten Tonn, Knut Schäkel, Martin Bornhäuser, Michael P. Bachmann, Manfred P. Wirth, Gustavo Baretton, and Marc Schmitz
E-Jahr:2015
Jahr:02 Mar 2015
Umfang:14 S.
Fussnoten:Gesehen am 02.05.2017
Titel Quelle:Enthalten in: OncoImmunology
Ort Quelle:Abingdon : Taylor & Franics, 2012
Jahr Quelle:2015
Band/Heft Quelle:4(2015), 6, Artikel-ID e1008342, Seite 1-14
ISSN Quelle:2162-402X
Abstract:Dendritic cells (DCs) essentially contribute to the induction and regulation of innate and adaptive immunity. Based on these important properties, DCs may profoundly influence tumor progression in patients. However, little is known about the role of distinct human DC subsets in primary tumors and their impact on clinical outcome. In the present study, we investigated the characteristics of human 6-sulfo LacNAc (slan) DCs in clear cell renal cell carcinoma (ccRCC). slanDCs have been shown to display various tumor-directed properties and to accumulate in tumor-draining lymph nodes from patients. When evaluating 263 ccRCC and 227 tumor-free tissue samples, we found increased frequencies of slanDCs in ccRCC tissues compared to tumor-free tissues. slanDCs were also detectable in the majority of 24 metastatic lymph nodes and 67 distant metastases from ccRCC patients. Remarkably, a higher density of slanDCs was significantly associated with a reduced progression-free, tumor-specific or overall survival of ccRCC patients. Tumor-infiltrating slanDCs displayed an immature phenotype expressing interleukin-10. ccRCC cells efficiently impaired slanDC-induced T-cell proliferation and programming as well as natural killer (NK) cell activation. In conclusion, these findings indicate that higher slanDC numbers in ccRCC tissues are associated with poor prognosis. The induction of a tolerogenic phenotype in slanDCs leading to an insufficient activation of innate and adaptive antitumor immunity may represent a novel immune escape mechanism of ccRCC. These observations may have implications for the design of therapeutic strategies that harness tumor-directed functional properties of DCs against ccRCC.
DOI:doi:10.1080/2162402X.2015.1008342
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: http://dx.doi.org/10.1080/2162402X.2015.1008342
 DOI: https://doi.org/10.1080/2162402X.2015.1008342
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:ccRCC, clear cell renal cell carcinoma
 CTLs, cytotoxic T cells
 DCs, dendritic cells
 dendritic cells
 FCS, fetal calf serum
 HLA, human leukocyte antigen
 IFNγ, interferonγ
 IL, interleukin
 ILT, immunoglobulin-like transcript
 LPS, lipopolysaccharide
 NK cells, natural killer cells
 PBMCs, peripheral blood mononuclear cells
 PMA, phorbol myristate acetate
 renal cell carcinoma
 slan, 6-sulfo LacNAc
 T cells
 Th1 cells, T helper type I cells
 TMAs, tissue microarrays
 TNF-α, tumor necrosis factor-α
 tumor immunology
K10plus-PPN:1557698473
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68114959   QR-Code
zum Seitenanfang